CanReview Selected to Build Pan-Canadian Single Research Ethics Board Review Process

The Accelerating Clinical Trials (ACT) consortium, through an independent, international review panel, has selected CanReview to set up, initiate, and conduct a pan-Canadian single REB review and approval process with strict timelines. Currently, researchers who wish to conduct a multi-centre randomized controlled trial (RCT) across Canada are required to get multiple research ethics board (REB) approvals […]

Ontario Announces Support for Clinical Trials in Phase II of Province’s Life Sciences Strategy

The Government of Ontario has announced new investments in the province’s thriving life sciences sector, including funding that will strengthen Ontario’s clinical trials environment. Unveiled today, the next phase of Ontario’s life sciences strategy commits an additional $146 million in support of tools and programs that will help establish Ontario as a global biomanufacturing and […]

Canadians Want More Options for Remote or Virtual Clinical Trials, New Survey Finds

During the COVID-19 pandemic, Canada’s clinical trials community was forced to adapt its approach to conducting clinical trials, offering innovative options for decentralized or hybrid trials, including virtual or remote participation. These novel approaches have the potential to increase access and equity in clinical trials, but how do trial participants and potential participants feel about […]

Ontario Advancing Homegrown Research and Innovation

The Ontario government is investing nearly $200 million over the next three years to help advance Ontario-made research and innovation at six leading research institutes. This funding will help keep ideas, expertise and intellectual property in the province and support long-term economic growth. “The Ontario government is proud to support homegrown research and innovation at […]

6 clinical trial myths busted

The goal of a clinical trial is to improve medical treatments and peoples’ health and well-being. Clinical trials can provide access to urgently needed lifesaving therapies and lead to better outcomes for current and future patients. In this article, some common misconceptions patients and the public have about clinical trials, and the truth behind them. […]